James Maguire, MD
Emergency Medicine · Freedom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Maguire’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A94918 · Current
Licensed to practise in California · since 2006 · expires 2028-02-29 · George Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$50,561
Medicare paid this office $50,561 for 491 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 215 | $18,912 | $86 |
| Short return visit (20+ min) | 115 | $7,028 | $61 |
| New patient visit (30+ min) | 77 | $5,923 | $77 |
| Long return visit (40+ min) | 44 | $5,670 | $129 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 37 | $5,172 | $140 |
See all 10 services
| Return visit (30+ min) | 215 | $18,912 | $86 |
| Short return visit (20+ min) | 115 | $7,028 | $61 |
| New patient visit (30+ min) | 77 | $5,923 | $77 |
| Long return visit (40+ min) | 44 | $5,670 | $129 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 37 | $5,172 | $140 |
| New patient visit (45+ min) | 14 | $1,676 | $120 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 29 | $1,508 | $50 |
| New patient visit (15+ min) | 28 | $1,463 | $52 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 23 | $373 | $16 |
| Automated urinalysis test | 80 | $178 | $2 |
Who their Medicare patients are
491 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 11% · Women 62% · Also on Medicaid 13% · Health risk score 0.90. At or below the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 56% · Diabetes 16% · Atrial fibrillation 15% · Depression 14% · Coronary heart disease 13% · Chronic kidney disease 13% · Cancer 13% · Heart failure 8% · COPD 8% · Stroke 4% · Dementia 3%.
The office billed $208,692, Medicare allowed $74,676 and paid $50,561; for 780 services of 45 kinds; $77 of it was for drugs given in the office and $50,484 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 491 | 780 | 74 | 0.90 | $208,692 | $50,561 |
| 2023 | 423 | 677 | 75 | 0.94 | $168,268 | $48,031 |
| 2022 | 420 | 699 | 73 | 0.99 | $144,182 | $41,275 |
| 2021 | 370 | 638 | 74 | 1.16 | $141,061 | $41,648 |
| 2020 | 287 | 425 | 73 | 1.13 | $100,378 | $23,324 |
| 2019 | 472 | 760 | 73 | 1.09 | $166,763 | $38,616 |
| 2018 | 425 | 739 | 72 | 1.13 | $152,420 | $35,783 |
| 2017 | 380 | 568 | 73 | 1.09 | $133,129 | $29,786 |
| 2016 | 424 | 595 | 72 | 1.05 | $143,167 | $32,397 |
| 2015 | 374 | 569 | 72 | 1.10 | $125,866 | $31,142 |
| 2014 | 357 | 521 | 71 | 0.99 | $114,938 | $26,816 |
| 2013 | 366 | 516 | 71 | 0.99 | $100,850 | $24,390 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 247 | $26,751 | $104 |
| Short return visit (20+ min) | 102 | $7,032 | $67 |
| Long return visit (40+ min) | 30 | $4,437 | $148 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 21 | $2,935 | $140 |
| New patient visit (30+ min) | 36 | $2,846 | $79 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 22 | $1,156 | $50 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $194 | $16 |
| Automated urinalysis test | 78 | $180 | $2 |
2022: 10 services
| Return visit (30+ min) | 144 | $16,169 | $109 |
| Short return visit (20+ min) | 226 | $15,121 | $66 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 61 | $3,145 | $51 |
| New patient visit (30+ min) | 31 | $2,212 | $71 |
| New patient visit (15+ min) | 11 | $656 | $60 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 17 | $258 | $15 |
| Diphtheria and tetanus vaccine (7 years or older) | 11 | $222 | $20 |
| Administration of vaccine | 11 | $155 | $14 |
| Removal of impacted ear wax by washing | 12 | $148 | $12 |
| Automated urinalysis test | 62 | $137 | $2 |
2021: 6 services
| Return visit (30+ min) | 239 | $26,497 | $102 |
| Short return visit (20+ min) | 102 | $7,534 | $70 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 52 | $2,719 | $51 |
| New patient visit (30+ min) | 20 | $1,374 | $69 |
| Injection of drug or substance under skin or into muscle | 15 | $231 | $12 |
| Automated urinalysis test | 57 | $140 | $2 |
2020: 4 services
| Return visit (30+ min) | 203 | $16,294 | $78 |
| Short return visit (20+ min) | 62 | $3,482 | $55 |
| New patient visit (30+ min) | 23 | $1,471 | $64 |
| Automated urinalysis test | 46 | $103 | $2 |
2019: 8 services
| Return visit (30+ min) | 313 | $26,128 | $79 |
| Short return visit (20+ min) | 131 | $7,244 | $53 |
| New patient visit (30+ min) | 32 | $2,022 | $63 |
| Injection of drug or substance under skin or into muscle | 18 | $298 | $14 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $287 | $15 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 14 | $227 | $16 |
| Automated urinalysis test | 69 | $173 | $2 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 17 | $2 | None |
2018: 6 services
| Return visit (30+ min) | 284 | $24,386 | $78 |
| Short return visit (20+ min) | 107 | $5,802 | $52 |
| New patient visit (30+ min) | 33 | $2,090 | $63 |
| Injection of drug or substance under skin or into muscle | 16 | $421 | $18 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 23 | $389 | $16 |
| Automated urinalysis test | 80 | $225 | $3 |
2017: 6 services
| Return visit (30+ min) | 228 | $18,762 | $74 |
| Short return visit (20+ min) | 126 | $6,099 | $47 |
| New patient visit (30+ min) | 32 | $1,852 | $58 |
| Injection of drug or substance under skin or into muscle | 12 | $262 | $20 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 14 | $187 | $12 |
| Automated urinalysis test | 43 | $144 | $3 |
2016: 5 services
| Return visit (30+ min) | 254 | $19,648 | $74 |
| Short return visit (20+ min) | 132 | $6,654 | $48 |
| New patient visit (30+ min) | 35 | $2,477 | $71 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 17 | $211 | $12 |
| Automated urinalysis test | 44 | $133 | $3 |
2015: 6 services
| Return visit (30+ min) | 179 | $16,752 | $85 |
| Short return visit (20+ min) | 155 | $8,423 | $52 |
| New patient visit (30+ min) | 29 | $1,859 | $64 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $161 | $12 |
| Short return visit | 11 | $123 | $11 |
| Automated urinalysis test | 32 | $102 | $3 |
2014: 7 services
| Return visit (30+ min) | 147 | $12,296 | $76 |
| Short return visit (20+ min) | 161 | $8,670 | $48 |
| New patient visit (15+ min) | 32 | $1,512 | $47 |
| New patient visit (30+ min) | 21 | $1,291 | $61 |
| Short return visit | 11 | $394 | $36 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 14 | $174 | $12 |
| Automated urinalysis test | 39 | $121 | $3 |
2013: 6 services
| Short return visit (20+ min) | 209 | $11,672 | $50 |
| Return visit (30+ min) | 68 | $5,726 | $80 |
| New patient visit (15+ min) | 58 | $2,878 | $50 |
| New patient visit (30+ min) | 24 | $1,439 | $60 |
| Short return visit | 14 | $401 | $29 |
| Automated urinalysis test | 33 | $104 | $3 |
Medicaid work
$18,998 in 2024
Medicaid paid $18,998 for 180 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 126 | $13,101 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique | 27 | $3,925 |
| Short return visit (20+ min) | 27 | $1,972 |
| 2024 | 180 | 3 | 29 | $18,998 |
| 2023 | 377 | 3 | 42 | $32,310 |
| 2022 | 376 | 4 | 33 | $27,364 |
| 2021 | 258 | 2 | 36 | $22,364 |
| 2020 | 239 | 3 | 37 | $15,339 |
| 2019 | 561 | 3 | 55 | $39,988 |
| 2018 | 389 | 2 | 38 | $28,520 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 250 | $23,721 |
| Short return visit (20+ min) | 110 | $6,843 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique | 17 | $1,746 |
2022
| Short return visit (20+ min) | 250 | $17,252 |
| Return visit (30+ min) | 84 | $8,689 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 26 | $1,309 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 16 | $115 |
2021
| Return visit (30+ min) | 228 | $20,225 |
| Short return visit (20+ min) | 30 | $2,139 |
2020
| Return visit (30+ min) | 158 | $12,447 |
| Short return visit (20+ min) | 47 | $2,591 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 34 | $301 |
2019
| Return visit (30+ min) | 388 | $30,476 |
| Short return visit (20+ min) | 148 | $9,269 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 25 | $242 |
2018
| Return visit (30+ min) | 268 | $21,350 |
| Short return visit (20+ min) | 121 | $7,169 |
Drugs they prescribed that Part D paid
$4,962
Pharmacies billed $4,962 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (14 of 394) in 2024. At or below the middle of the specialty; the typical emergency medicine clinician is at 12%.
347 generic and fewer than 11 brand-name prescriptions · $4,962 in drug cost · 159 antibiotic prescriptions to 141 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Paxlovid | 20 | $1,429 | $71 |
| Albuterol Sulfate Hfa | 26 | $779 | $29 |
| Amoxicillin-Clavulanate Potass | 35 | $249 | $7 |
| Cephalexin | 47 | $230 | $5 |
| Doxycycline Hyclate | 19 | $154 | $8 |
See all 12 drugs
| Paxlovid | 20 | $1,429 | $71 |
| Albuterol Sulfate Hfa | 26 | $779 | $29 |
| Amoxicillin-Clavulanate Potass | 35 | $249 | $7 |
| Cephalexin | 47 | $230 | $5 |
| Doxycycline Hyclate | 19 | $154 | $8 |
| Mupirocin | 20 | $138 | $7 |
| Baclofen | 14 | $109 | $8 |
| Azithromycin | 23 | $97 | $4 |
| Hydrocodone-Acetaminophen | 13 | $73 | $6 |
| Triamcinolone Acetonide | 15 | $71 | $4 |
| Prednisone | 27 | $69 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $33 | $3 |
Year by year
| 2024 | 394 | 284 | 4% (14) | None | $4,962 |
| 2023 | 415 | 274 | 3% (12) | 5% | $5,761 |
| 2022 | 323 | 227 | 5% (17) | 7% | $8,748 |
| 2021 | 262 | 170 | 6% (16) | None | $3,210 |
| 2020 | 203 | 132 | None | None | $3,004 |
| 2019 | 348 | 223 | 6% (20) | 14% | $7,252 |
| 2018 | 257 | 170 | 11% (28) | None | $5,784 |
| 2017 | 220 | 148 | 11% (25) | 9% | $3,912 |
| 2016 | 243 | 175 | 13% (31) | None | $4,537 |
| 2015 | 268 | 182 | 16% (44) | None | $4,739 |
| 2014 | 252 | 158 | 18% (45) | None | $3,935 |
| 2013 | 252 | 168 | 14% (34) | None | $8,585 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Albuterol Sulfate Hfa | 19 | $728 | $38 |
| Cephalexin | 55 | $484 | $9 |
| Doxycycline Hyclate | 20 | $334 | $17 |
| Mupirocin | 32 | $333 | $10 |
| Ofloxacin | 14 | $276 | $20 |
| Amoxicillin-Clavulanate Potass | 24 | $270 | $11 |
| Paxlovid (Eua) | 22 | $209 | $9 |
| Sulfamethoxazole-Trimethoprim | 27 | $174 | $6 |
| Prednisone | 41 | $149 | $4 |
| Triamcinolone Acetonide | 17 | $86 | $5 |
| Azithromycin | 12 | $74 | $6 |
| Naproxen | 11 | $54 | $5 |
2022: 10 drugs
| Cephalexin | 51 | $420 | $8 |
| Albuterol Sulfate Hfa | 14 | $363 | $26 |
| Doxycycline Hyclate | 14 | $326 | $23 |
| Amoxicillin-Clavulanate Potass | 22 | $219 | $10 |
| Paxlovid (Eua) | 18 | $191 | $11 |
| Mupirocin | 17 | $181 | $11 |
| Sulfamethoxazole-Trimethoprim | 18 | $97 | $5 |
| Prednisone | 20 | $85 | $4 |
| Hydrocodone-Acetaminophen | 11 | $79 | $7 |
| Naproxen | 14 | $78 | $6 |
2021: 7 drugs
| Cephalexin | 45 | $353 | $8 |
| Mupirocin | 22 | $217 | $10 |
| Amoxicillin-Clavulanate Potass | 16 | $168 | $10 |
| Sulfamethoxazole-Trimethoprim | 28 | $142 | $5 |
| Prednisone | 19 | $75 | $4 |
| Hydrocodone-Acetaminophen | 13 | $63 | $5 |
| Naproxen | 11 | $44 | $4 |
2020: 4 drugs
| Cephalexin | 32 | $173 | $5 |
| Sulfamethoxazole-Trimethoprim | 22 | $103 | $5 |
| Mupirocin | 11 | $75 | $7 |
| Prednisone | 18 | $59 | $3 |
2019: 11 drugs
| Ventolin Hfa | 17 | $946 | $56 |
| Cephalexin | 58 | $409 | $7 |
| Doxycycline Hyclate | 11 | $286 | $26 |
| Amoxicillin-Clavulanate Potass | 19 | $178 | $9 |
| Azithromycin | 20 | $175 | $9 |
| Hydrocodone-Acetaminophen | 15 | $122 | $8 |
| Prednisone | 23 | $116 | $5 |
| Mupirocin | 14 | $107 | $8 |
| Polymyxin B Sul-Trimethoprim | 11 | $96 | $9 |
| Sulfamethoxazole-Trimethoprim | 16 | $91 | $6 |
| Triamcinolone Acetonide | 13 | $79 | $6 |
2018: 5 drugs
| Cephalexin | 37 | $219 | $6 |
| Hydrocodone-Acetaminophen | 22 | $163 | $7 |
| Prednisone | 20 | $74 | $4 |
| Azithromycin | 12 | $74 | $6 |
| Ciprofloxacin | 12 | $61 | $5 |
2017: 4 drugs
| Mupirocin | 16 | $160 | $10 |
| Cephalexin | 21 | $138 | $7 |
| Hydrocodone-Acetaminophen | 17 | $109 | $6 |
| Naproxen | 16 | $63 | $4 |
2016: 4 drugs
| Hydrocodone-Acetaminophen | 26 | $215 | $8 |
| Mupirocin | 17 | $178 | $10 |
| Cephalexin | 32 | $170 | $5 |
| Prednisone | 13 | $62 | $5 |
2015: 6 drugs
| Proair Hfa | 11 | $560 | $51 |
| Mupirocin | 16 | $259 | $16 |
| Hydrocodone-Acetaminophen | 35 | $242 | $7 |
| Cephalexin | 43 | $223 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $163 | $14 |
| Prednisone | 11 | $47 | $4 |
2014: 5 drugs
| Hydrocodone-Acetaminophen | 36 | $268 | $7 |
| Amox Tr-Potassium Clavulanate | 14 | $242 | $17 |
| Cephalexin | 33 | $190 | $6 |
| Azithromycin | 21 | $180 | $9 |
| Ciprofloxacin | 13 | $76 | $6 |
2013: 5 drugs
| Nitrofurantoin Mono-Macro | 12 | $388 | $32 |
| Levofloxacin | 13 | $267 | $21 |
| Cephalexin | 25 | $185 | $7 |
| Azithromycin | 11 | $143 | $13 |
| Hydrocodone-Acetaminophen | 25 | $141 | $6 |
Professional record
- NPI
- 1184644346
- Licence
- CA A94918California A94918: Current · expires 2028-02-29
- Trained
- George Washington University School of Medicine, 2004
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207P00000X (207P00000X)
- Mailing address
- 2025 Soquel Ave, Santa Cruz, CA, 95062
- NPI first listed
- 2006-07-20
- NPI last updated
- 2011-12-08
This is when the NPI record was last certified, not a medical board exam.